![Marc Schrader](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: 93 459 $ as of 2026-05-30
Marc Schrader is currently working as the Chief Technology Officer at Santhera Pharmaceuticals Holding AG.
He started this position in 2024.
Mr. Schrader has an undergraduate degree from the University of Basel.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-12-30 | 4,480 ( 0.03% ) | 93 459 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| SANTHERA PHARMACEUTICALS HOLDING AG | Chief Tech/Sci/R&D Officer | 2022-08-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 2 |
|---|---|
Santhera Pharmaceuticals Holding AG
 Santhera Pharmaceuticals Holding AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of neuromuscular diseases | Health Technology |
University of Basel
 University of Basel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Select your edition
All financial news and data tailored to specific country editions
